Results 1 - 10 of 844

< 1 2 3 ... 84 85 >

• Structure-functional selectivity relationship studies of ?-arrestin-biased dopamine D? receptor agonists.

  [DOI: 10.1021/jm300603y]
  
• Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT?A/5-HT?A/5-HT? and dopamine D?/D? receptors.

  [DOI: 10.1016/j.ejmech.2012.11.042]
  
• Gibon J; Richaud P; Bouron A. Hyperforin changes the zinc-storage capacities of brain cells., Neuropharmacology

  [PubMed: 21854792]
  [DOI: 10.1016/j.neuropharm.2011.08.0]
  
• Vohra M; Sandbhor M; Wozniak A. Efficient synthesis of deuterium labeled hydroxyzine and aripiprazole., Journal of labelled compounds & radiopharmaceuticals

  [PubMed: 26011470]
  [DOI: 10.1002/jlcr.3298]
  
• Jensen JB; du Jardin KG; Song D; Budac D; Smagin G; Sanchez C; Pehrson AL. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation., European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

  [PubMed: 24284262]
  [DOI: 10.1016/j.euroneuro.2013.10.01]
  
• Kuno F; Okada Y; Arao T; Kurozumi A; Tanaka Y. [Case of graves' disease with remarkable psychiatric symptoms]., Journal of UOEH

  [PubMed: 25787102]
  [DOI: 10.7888/juoeh.37.49]
  
• Mohamed S; Johnson GR; Chen P; Lawrence DD; Planeta B; Thase ME; Huang GD; Zisook S; Rao SD; Pilkinton PD; Wilcox JA; Iranmanesh A; Sapra M; Hicks PB; Jurjus G; Michalets JP; Aslam M; Beresford T; Anderson KD; Fernando R; Ramaswamy S; Kasckow J; Westermeyer J; Yoon G; Davis LL; D'Souza DC; Larson G; Anderson WG; Klatt M; Fareed A; Thompson SI; Carrera CJ; Williams SS; Juergens TM; Albers LJ; Yoon J; Nasdahl CS; Villarreal G; Winston JL; Nogues CA; Connolly KR; Tapp A; Jones KA; Khatkhate G; Marri S; Suppes T; Gleason TC; LaMotte J; Hurley R; Mayeda AR; Niculescu AB 3rd; Fischer BA; Loreck DJ; Rosenlicht N; Lieske S; Finkel MS; Little JT; Vertrees JE; Weingart K; Tal I; Scrymgeour A. Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial., JAMA

  [PubMed: 28697253]
  [DOI: 10.1001/jama.2017.8036]
  
• Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study., Journal of clinical psychopharmacology

  [PubMed: 28129308]
  [DOI: 10.1097/JCP.0000000000000663]
  
• Fava M; Okame T; Matsushima Y; Perry P; Weiller E; Baker RA. Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning., The international journal of neuropsychopharmacology

  [PubMed: 27784751]
  [DOI: 10.1093/ijnp/pyw087]
  
• Arandjelovic K; Eyre HA; Lavretsky H. Clinicians' Views on Treatment-Resistant Depression: 2016 Survey Reports., The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  [PubMed: 27591914]
  [DOI: 10.1016/j.jagp.2016.05.010]